<DOC>
	<DOCNO>NCT00812682</DOCNO>
	<brief_summary>This study evaluate perception physician patient approve adjustable dose SymbicortÂ® 160/4,5 . Symbicort maintenance dose adjust within approve dose range 1x2 - 4x2 inhalation per day , level asthma symptom . Patients physicians perception new dose schedule evaluate mean questionnaire completion direct questioning .</brief_summary>
	<brief_title>Physician Patient Perception Adjustable Maintenance Dosing Symbicort Turbuhaler</brief_title>
	<detailed_description />
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<criteria>Minimum 6 month history asthma treatment inhaled corticosteroid least 3 month prior visit 1 and/or history short term variation airway function asthma symptom respond promptly convent Patients use combination ( inhaled corticosteroid long act beta2agonist appropriate , i.e . control inhaled corticosteroid alone ) . Asthma exacerbation require oral corticosteroid treatment four week prior visit 1 Upper Respiratory Tract Infection previous four week Severe cardiovascular disease significant concomitant disease , may interfere conduct study . Women enrol trial planning pregnancy take adequate contraceptive measure appropriate . Previous enrollment clinical study Known suspect hypersensitivity budesonide , formoterol inhale lactose</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>SYMBICORT AMD</keyword>
</DOC>